These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 12733839)

  • 1. Fully vaccinated children are rare: immunization coverage and seroprevalence in Austrian school children.
    Ringler M; Göbel G; Möst J; Weithaler K
    Eur J Epidemiol; 2003; 18(2):161-70. PubMed ID: 12733839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seroprevalences of antibodies against pertussis, diphtheria, tetanus, measles, mumps and rubella: A cross-sectional study in children following vaccination procedure in Guangzhou, China.
    Li YT; Luo XQ; Zhong XB; Cai LM; Zhu LP; Chen XQ; Wang KC; Chen ZG
    Vaccine; 2020 May; 38(23):3960-3967. PubMed ID: 32321685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High seroprevalence of varicella, measles, mumps, rubella and pertussis antibodies in first-grade medical students.
    Socan M; Berginc N
    Wien Klin Wochenschr; 2008; 120(13-14):422-6. PubMed ID: 18726668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pediatric sentinel surveillance of vaccine-preventable diseases in Italy.
    Ciofi Degli Atti ML; Salmaso S; Bella A; Arigliani R; Gangemi M; Chiamenti G; Brusoni G; Tozzi AE;
    Pediatr Infect Dis J; 2002 Aug; 21(8):763-8. PubMed ID: 12192166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroprevalence of vaccine-preventable diseases among young children in the United Arab Emirates.
    Al-Mekaini LA; Kamal SM; Al-Jabri O; Soliman M; Alshamsi H; Narchi H; Souid AK; Alsuwaidi AR
    Int J Infect Dis; 2016 Sep; 50():67-71. PubMed ID: 27457919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistence of antibodies in 4-8 year old Austrian children after vaccination with hexavalent DTaP-HBV-IPV/Hib and MMR vaccines.
    Paulke-Korinek M; Fischmeister G; Grac A; Rendi-Wagner P; Kundi M; Mohsenzadeh-Rabbani A; Moritz K; Fenninger B; Jarisch R; Jasinska J; Holzmann H; Wiedermann U; Kollaritsch H
    Vaccine; 2011 Jul; 29(32):5130-6. PubMed ID: 21624412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic evaluation of the 7-vaccine routine childhood immunization schedule in the United States, 2001.
    Zhou F; Santoli J; Messonnier ML; Yusuf HR; Shefer A; Chu SY; Rodewald L; Harpaz R
    Arch Pediatr Adolesc Med; 2005 Dec; 159(12):1136-44. PubMed ID: 16330737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parental Vaccine Hesitancy and Association With Childhood Diphtheria, Tetanus Toxoid, and Acellular Pertussis; Measles, Mumps, and Rubella; Rotavirus; and Combined 7-Series Vaccination.
    Nguyen KH; Srivastav A; Lindley MC; Fisher A; Kim D; Greby SM; Lee J; Singleton JA
    Am J Prev Med; 2022 Mar; 62(3):367-376. PubMed ID: 35190101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using Locally Derived Seroprevalence Data on Measles, Mumps, Rubella, and Varicella by Birth Cohort to Determine Risks for Vaccine-Preventable Diseases During International Travel.
    Rosario-Rosario G; Gareca M; Kincaid H; Knouse MC
    J Travel Med; 2015; 22(6):396-402. PubMed ID: 26412393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination coverage among children enrolled in Head Start programs or day care facilities or entering school.
    Jiles RB; Fuchs C; Klevens RM
    MMWR CDC Surveill Summ; 2000 Sep; 49(9):27-38. PubMed ID: 11016876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination coverage rates and attitudes towards mandatory vaccinations among healthcare personnel in tertiary-care hospitals in Greece.
    Maltezou HC; Tseroni M; Drositis I; Gamaletsou MN; Koukou DM; Bolikas E; Peskelidou E; Daflos C; Panagiotaki E; Ledda C; Pavli A; Moussas N; Kontogianni S; Svarna E; Ploumidis M; Spyrou A; Chini M; Adamis G; Lourida A; Hatzigeorgiou D; Gargalianos P; Syrogiannopoulos G; Sipsas NV
    Expert Rev Vaccines; 2022 Jun; 21(6):853-859. PubMed ID: 35382665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroprevalence of Measles, Rubella, Tetanus, and Diphtheria Antibodies among Children in Haiti, 2017.
    Minta AA; Andre-Alboth J; Childs L; Nace D; Rey-Benito G; Boncy J; Adrien P; Francois J; Phaïmyr Jn Charles N; Blot V; Vanden Eng J; Priest JW; Rogier E; Tohme RA
    Am J Trop Med Hyg; 2020 Oct; 103(4):1717-1725. PubMed ID: 32618256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Seroprevalence of antibodies against measles, rubella, mumps and varicella among school children in Madrid].
    Gil Miguel A; Astasio Arbiza P; Ortega Molina P; Domínguez Rojas V; González López A
    An Esp Pediatr; 1999 May; 50(5):459-62. PubMed ID: 10394183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase III, open-label, randomised multicentre study to evaluate the immunogenicity and safety of a booster dose of two different reduced antigen diphtheria-tetanus-acellular pertussis-polio vaccines, when co-administered with measles-mumps-rubella vaccine in 3 and 4-year-old healthy children in the UK.
    Marlow R; Kuriyakose S; Mesaros N; Han HH; Tomlinson R; Faust SN; Snape MD; Pollard AJ; Finn A
    Vaccine; 2018 Apr; 36(17):2300-2306. PubMed ID: 29576304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroprevalence of chronic hepatitis B virus infection and immunity to measles, rubella, tetanus and diphtheria among schoolchildren aged 6-7 years old in the Solomon Islands, 2016.
    Breakwell L; Anga J; Cooley G; Ropiti L; Gwyn S; Wannemuehler K; Woodring J; Ogaoga D; Martin D; Patel M; Tohme RA
    Vaccine; 2020 Jun; 38(30):4679-4686. PubMed ID: 32473876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination coverage in hard to reach Roma children in Slovenia.
    Kraigher A; Vidovic M; Kustec T; Skaza A
    Coll Antropol; 2006 Dec; 30(4):789-94. PubMed ID: 17243551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are we hitting immunity targets? The 2006 age-specific seroprevalence of measles, mumps, rubella, diphtheria and tetanus in Belgium.
    Theeten H; Hutse V; Hens N; Yavuz Y; Hoppenbrouwers K; Beutels P; Vranckx R; Van Damme P
    Epidemiol Infect; 2011 Apr; 139(4):494-504. PubMed ID: 20587123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measles, mumps, rubella, and varicella seroprevalence in refugees in Germany in 2015.
    Jablonka A; Happle C; Grote U; Schleenvoigt BT; Hampel A; Dopfer C; Hansen G; Schmidt RE; Behrens GM
    Infection; 2016 Dec; 44(6):781-787. PubMed ID: 27449329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Measles, mumps and rubella: vaccination rate and seroprevalence in 8th grade students of 8 different sites in Switzerland 1995/96].
    Stohrer-Draxl P; Amstad H; Grize L; Gassner M; Takken-Sahli K; Bourquin C; Braun-Fahrländer C
    Praxis (Bern 1994); 1999 Jun; 88(24):1069-77. PubMed ID: 10420798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Seroprevalence of measles, rubella, mumps and varicella in health workers in the Community of Madrid].
    Rodríguez ML; Martínez D; Santos-Sancho JM; Borda JR; Orero A
    Rev Esp Quimioter; 2014 Jun; 27(2):98-101. PubMed ID: 24940889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.